Laura Laviolette

Laura Laviolette currently serves as Associate Director, Immuno-Oncology at Dragonfly Therapeutics, Inc., since October 2021. Prior to this role, Laura held the position of Associate Director in Oncology Research, as well as Senior Scientist, at bluebird bio from September 2019 to October 2021. Laura's experience also includes a tenure at ImmunoGen, Inc. from May 2016 to August 2019, where Laura progressed from Scientist I to Scientist III, focusing on antibody-drug conjugate cancer therapeutics and providing leadership in early-stage research projects. Laura began a post-doctoral research fellowship at Massachusetts General Hospital in 2010, studying the human Folliculin tumor suppressor protein, after earning a PhD in Cellular and Molecular Medicine from the University of Ottawa and a BS in Biology from Mount Allison University.